Introduction
A large number of genetic, cell biological and biochemical approaches have provided significant information on the roles of the ras family genes in normal cell proliferation and differentiation as well as oncogenesis (Barbacid, 1987; Lowy and Willumsen, 1993; Malumbres and Pellicer, 1998) . In mammals, three distinct ras genes (H-ras, N-ras and K-ras) have been identified, with each encoding homologous but distinct 21-kDa proteins, H-Ras, N-Ras, K-Ras4A and K-Ras4B (Barbacid, 1987; Lowy and Willumsen, 1993; Hancock, 2003) . These four Ras proteins are believed to have similar biological and biochemical properties. They are located on the inner surface of the plasma membrane (Willingham et al., 1980) and function as molecular switches that are activated upon binding GTP via reaction catalysed by Ras guanine nucleotide exchange factors (GEFs). They are inactivated when the bound GTP is converted to GDP by both intrinsic GTPase activity and GTPase-activating proteins (GAPs) (Lowy and Willumsen, 1993; Hancock, 2003; Hancock and Parton, 2005; Plowman and Hancock, 2005) .
On the other hand, there have been several reports indicating that the four Ras proteins have different biological properties and participate in different signaling cascades. After post-translational modifications, including farnesylation of the CAAX motif, farnesylated K-Ras is directly targeted to the plasma membrane, whereas all other Ras isoforms undergo palmitoylation and traffic to the plasma membrane through the Golgi secretory pathway (Apolloni et al., 2000) . Rapid exchange of H-Ras occurs between the plasma membrane and the Golgi driven by a cycle of depalmitoylation and repalmitoylation (Rocks et al., 2005) . In the plasma membrane, K-Ras stably localizes to non-raft lipid microdomains irrespective of bound nucleotide (Prior et al., 2001) . In contrast, H-Ras is dynamically associated with the plasma membrane; it localizes to lipid rafts when in an inactive state and moves to nonraft subdomains when activated (Prior et al., 2001) . Tumorigenic mutations of each ras gene are related to specific tissue types (Barbacid, 1987; Balmain and Brown, 1988; Bos, 1989) . A transformation assay using different cell lines revealed cell-specific differences in the intrinsic transforming potential of the three ras genes (Maher et al., 1995) . Of the various types of Ras GEFs, Ras-GRF (Cdc25Mm) selectively activates H-Ras, but activates neither N-Ras nor K-Ras4B in NIH3T3 cells (Jones and Jackson, 1998) , while smgGDS is inactive on H-Ras but does interact with K-Ras4B in vitro (Mizuno et al., 1991) .
The mammalian H-ras, N-ras and K-ras genes are ubiquitously expressed (Leon et al., 1987) , raising questions concerning the functional specificity or redundancy of each of these ras genes in embryonic development. Studies in mice indicate that the ras gene function is partially dispensable for normal development and cell survival. H-ras (Ise et al., 2000) and N-ras (Umanoff et al., 1995) single mutant mice and H-ras and N-ras double mutant mice (Esteban et al., 2001) grow normally. On the other hand, K-ras is essential for normal development of mice (Johnson et al., 1997; Koera et al., 1997) , but expression of the K-Ras4A splice variant is dispensable for development (Plowman et al., 2003) . Recently, Potenza et al. (2005) have shown that replacement of K-ras with H-ras supports normal embryonic development of mice; however, these mice developed dilated myocardiopathy associated with arterial hypertension in adulthood, suggesting that K-ras plays a specific role in the homeostasis of the cardiovascular system. In addition, mice deficient for N-ras were found to have impaired antiviral immune response and T-cell function (Pe´rez de Castro et al., 2003) .
Previously, we have generated three ras single mutant mice (Koera et al., 1997; Ise et al., 2000) and H-ras transgenic mice (Saitoh et al., 1990) . In this study, we first carried out in situ hybridization for the three ras mRNAs in wild-type mice at different embryonic stages to gain an insight into the functions of these genes. Then we compared the phenotypes of mice deficient in the H-ras, N-ras or K-ras gene as well as double or triple ras mutant mice in terms of embryonic and perinatal development. In accordance with previous reports (Koera et al., 1997) , the K-ras mutant mice were embryonically lethal, and their ventricular walls were extremely thin on E15.5. H-ras and N-ras single mutant mice and H-ras and N-ras double mutant mice were viable (Esteban et al., 2001) . On the other hand, N-ras À/À /K-ras þ /À mice were embryonically lethal, while N-ras À/À mice and K-ras þ /À mice were both viable. In addition, we found that H-ras À/À /K-ras À/À mice died earlier than K-ras À/À mice. To further investigate the functional relationship of the ras genes, we introduced a human H-ras transgene (Saitoh et al., 1990) into K-ras deficient mice with its own endogenous promoter to allow ubiquitous and increased expression, and found that the H-ras transgene rescued the mice from impaired cardiac development and lethality. Furthermore, the H-ras transgene rescued ras triple knockout mice from the embryonic lethality. We therefore conclude that the functions of ras genes are partially overlapping in embryonic and neonatal development.
Results

Distribution of ras mRNAs at the embryonic stage
We carried out in situ hybridization analysis for H-ras, N-ras and K-ras mRNAs at the embryonic stage (Figure 1 ). On E13.5, the hybridization signals for the three ras species were distributed throughout almost all tissues and organs, although the intensity varied among the three ras species and the tissues and organs (Figure 1a) . On E15.5, the mRNAs for each of the endogenous H-ras, N-ras and K-ras were uniformly expressed in the heart (Figure 1a) . However, of the single ras mutant mice, only K-ras mutant mice were embryonically lethal, as will be described later. These patterns of expression and intensity were maintained on E18.5 (data not shown). In human H-ras transgenic mice, the expression of human H-ras mRNA was ubiquitous and by and large higher than that of mouse H-ras mRNA in wild-type mice (Figures 1a and b) . Analyses showed that on E15.5 the hybridization signal for human H-ras mRNA was stronger than that for mRNAs of the three endogenous ras genes in thymus, heart, lung, liver and kidney ( Figure 1b) . Similar patterns of expression were seen on E13.5 (data not shown).
Generation of H-ras, N-ras and K-ras mutant mice We generated null ras alleles by deleting the exons of each ras gene ( Figure 2a ) and produced mice heterozygous for the mutation in one of the three ras genes. H-ras À/À and N-ras À/À mice were generated by intercrossing H-ras þ /À and N-ras þ /À mice, respectively. No H-Ras or N-Ras proteins were detected in the extracts from H-ras À/À or N-ras À/À mice, respectively ( Figure 2c ). In accordance with previous reports (Umanoff et al., 1995; Ise et al., 2000) , both H-ras À/À and N-ras À/À mice were found in the expected Mendelian distribution (Table 1) , grew normally, were fertile, exhibited no apparent abnormal behavior and grew no tumors spontaneously. K-ras À/À mice died at various embryonic stages between E12.5 and term (data not shown), as observed by us and others (Johnson et al., 1997; Koera et al., 1997) (Table 1) . K-ras À/À embryos were generated by the intercrossing of K-ras þ /À mice ( Figure 2b ), and no K-Ras protein was detected in the K-ras À/À embryos on E11.5 ( Figure 2c ). ras double mutant mice To generate mice lacking both the H-ras and N-ras genes, H-ras
/N-ras À/À mice were intercrossed. H-ras À/À /N-ras À/À double mutant mice were found among the weaned animals, although their number was lower than that expected from the intercrossing of H-ras Table 2 ), suggesting that such mice can survive with K-ras gene function alone. These findings, combined with the embryonic death of K-ras À/À mutant mice, suggest that at the embryonic stage of mouse development, K-ras has a distinct function and that either H-ras or N-ras cooperates for full viability of the embryo.
In the course of generating N-ras and K-ras double mutant mice, N-ras
þ /À mutant mice were not observed among the weaned mice. To determine the stage of embryonic death of N-ras
þ / þ mice and found that a majority of N-ras
þ /À mice died between E18.5 and term (Table 3 ). This finding suggests that N-Ras and K-Ras together play a role in mouse embryonic and neonatal development. Next, we examined the stage of embryonic death of H-ras À/À /K-ras À/À embryos to identify cooperative relationships between K-Ras and H-Ras in mouse development. Since H-ras À/À /K-ras þ /À mice were viable, we intercrossed H-ras À/À /K-ras þ /À mice to examine how far the H-ras Table 4 ). The genotype distribution of the embryos agreed with the expected ratio on E7.5 and E9.5, with H-ras À/À /K-ras À/À accounting for approximately onefourth of the embryos. However, we found only one H-ras À/À /K-ras À/À embryo among 76 embryos on E11.5, and this embryo was smaller than the other embryos from the same mother. Moreover, H-ras
embryos were not observed at all on E13.5, although H-ras
embryos were observed at the Figure 1 In situ hybridization analysis of H-ras, N-ras and K-ras mRNAs in mouse embryos. (a) In situ hybridization analysis of Hras, N-ras and K-ras mRNAs in sagittal sections of wild-type mice and of human H-ras mRNA in the human H-ras transgenic mice (Tg H-ras ) on E13.5 and E15.5. On the far right are hematoxylin-eosin-stained sagittal sections (HE) of the wild-type mice on E13.5 and E15.5. Magnified views of the heart on E15.5 are shown at the bottom. Arrows indicate the heart. (b) Levels of endogenous H-ras, N-ras and K-ras mRNAs in wild-type mice and human H-ras mRNA in the human H-ras transgenic mice. Data of representative hybridization are shown for major organs in arbitrary units defined by the analytical software used for the intensity of hybridization signals.
Partial functional overlap of three ras genes in mouse K Nakamura et al expected frequency (Table 4) . The death of H-ras À/À / K-ras À/À mice occurring earlier than that of K-ras
single mutant mice seen between E12.5 and term (Koera et al., 1997) thus suggests that H-Ras has a function that partially compensates for the loss of K-Ras in mouse development between E9.5 and E11.5.
The H-ras transgene eliminates overt abnormalities in the development of various genotypes of Ras mutant mice The above genetic analyses of the ras gene family suggest a functional overlap of the three ras genes in vivo. To test this hypothesis, we introduced a human H-ras transgene into single or multiple ras mutant mice. This transgene is under the regulation of its endogenous promoter and encodes the prototype H-Ras protein whose amino acid sequence is identical to that of mouse H-Ras protein (Saitoh et al., 1990 ). We also examined whether H-Ras could functionally compensate for the loss of K-Ras and/or N-Ras and thus rescue various types of ras mutant mice from the developmental defects. First, we introduced the H-ras transgene into K-ras À/À mice, which would die between E12.5 and term and have abnormal hearts with thin ventricular walls, Figure 2 Production of H-ras, N-ras and K-ras mutant mice. (a) Targeting constructs of the H-ras locus (upper panel), N-ras locus (middle panel) and K-ras locus (lower panel). Schematic drawings of a region of the H-ras gene that contains exon f to exon IV, a region of the N-ras gene that contains exon f to exon VI and a region of the K-ras gene that contains exon I are shown. The targeting vector of the H-ras gene has a neomycin resistance (neo) gene to disrupt the exon f to 5 0 part of exon IV, which contains an initiation codon and the first 160 amino-acid residues of H-Ras protein. The N-ras targeting vector has a neo gene to disrupt exon f to exon II, which contains an initiation codon and the first 97 amino-acid residues of N-Ras protein. The K-ras targeting vector has a neo gene to disrupt the 3 0 part of exon I, which encodes the 17 amino-acid residues containing the K-Ras effector domain. The H-ras probe, the N-ras probe and the K-ras probe used for screening of ES cell (embryonic stem cell) clones as well as mice are indicated as bars, together with the expected sizes of hybridizing restriction fragments from wild-type and mutant alleles. Abbreviation for the restriction enzyme sites: EI, EcoRI; EV, EcoRV; Xb, XbaI; Xh, XhoI; Sp, SpeI; HIII, HindIII; Ps, PstI; Kp, KpnI. (b) PCR analyses of representative tail biopsies or whole embryos. Genomic DNA was isolated from mice derived from the intercrosses of H-ras þ /À mice (left) and N-ras þ /À mice (middle). Genomic DNA was isolated from embryos derived from the intercross of K-ras þ /À mice (right). (c) Western blot analyses of H-Ras (left) and N-Ras (middle) expression in wild-type ( þ / þ ), heterozygous ( þ /À) and homozygous (À/À) mutant mice. In addition, analysis of K-Ras (right) expression in wild-type ( þ / þ ), heterozygous ( þ /À) and homozygous (À/À) mutant embryos at E11.5. H-Ras, N-Ras and K-Ras proteins were not detected in H-ras À/À , N-ras À/À and K-ras À/À mice embryos, respectively.
Partial functional overlap of three ras genes in mouse K Nakamura et al probably due to a deficiency in the proliferation of cardiomyocytes at E15.5 (Koera et al., 1997 and Figures 3b and e) . In contrast to K-ras À/À mice, K-ras À/À mice carrying H-ras transgenes survived (Table 5a) , reproduced (Table 5b ) and exhibited apparently normal hearts on E15.5 (Figures 3c and f) . Expression of the human H-ras mRNA was detected in hearts on E15.5 (Figure 1) , suggesting that H-Ras can functionally replace K-Ras in embryonic development, including cardiomyocyte proliferation.
Finally, we found that ras triple mutant mice deficient in all endogenous Ras proteins but carrying the human transgene were able to survive (Table 6 ). The number of birth and those weaned, albeit small, were in agreement with the expected values. These results show that H-Ras could functionally replace K-Ras and N-Ras, supporting the notion that Ras proteins are functionally overlapping during mouse embryonic development.
Discussion
In this study, we show that H-ras À/À /N-ras À/À mice are as viable as H-ras or N-ras single mutant mice, while K-ras À/À mice are lethal at various embryonic stages. Umanoff et al. (1995) also found that N-ras À/À mice are born and grow normally. We have previously shown that K-ras À/À mice have abnormal hearts with thin ventricular walls on E15.5 (Koera et al., 1997) . In situ hybridization analysis showed that all three ras genes are expressed in the heart on E13.5 and E15.5. These results suggest two possibilities. First, for embryonic development of the heart, only K-Ras function is required while H-Ras and N-Ras cannot compensate for loss of K-Ras function. Second, the intrinsic activities of H-Ras and N-Ras do not differ substantially from those of K-Ras in embryonic development of the heart at this stage, but the activities of endogenous H-Ras and N-Ras are not sufficient for normal development of the heart due to their subthreshold amounts, timing and organ and/or tissue of expression or intracellular localization. Rescue from the abnormal cardiac development and embryonic lethality of K-ras mutant mice by introduction of the human H-ras transgene supports the latter possibility.
The possibility that the intrinsic activities of H-Ras and N-Ras do not differ substantially from those of K-Ras in embryonic development is further supported by the findings that mice in which the K-ras gene was replaced with mouse H-ras cDNA grew normally until term (Potenza et al., 2005) . These 'knock-in mice' had H-Ras protein expressed exactly in the pattern of endogenous K-Ras protein in terms of timing, organ and tissue of expression. It should be noted, however, that the expression level of H-Ras protein was higher than that in wild-type mice since endogenous H-ras gene was intact (Potenza et al., 2005) . In this regard, these 'knock-in mice' were similar to our mice carrying human H-ras transgene in which human H-ras mRNA was more abundant than K-ras mRNA in wild-type mice (Figures 1a and b) . Thus these data, together with the present finding that human H-ras transgene rescued mutant mice from embryonic lethality, suggest that during mouse embryonic development the functions of the ras genes overlap, at least partially. It is possible that both K-Ras and H-Ras proteins can support normal development of the cardiovascular system during embryonic development. In parentheses are the number of dead embryos. P0 represents postnatal day 0. *P ¼ 0.00595 vs expected values (w-square test).
Table 4
Characterization of the H-ras K-ras double mutant mice
H-ras K-ras E 7.5 E 9.5 E 11.5 E 13.5 Expected (%) À/À +/+ 6 (19%) 6 (25%) 22 (29%) 8 (30%) 25 À/À +/À 19 (61%) 13 (54%) 53 (70%)* 19 (70%) 50 À/À À/À 6 (19%) 5 (21%) 1 (1%)** 0 (0%) 25 Total 31 24 76 27 100 *P ¼ 0.01306 and **P ¼ 0.00002 vs expected values (w-square test).
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In agreement with Esteban et al. (2001) , we found that H-ras À/À /N-ras À/À mice were viable, suggesting that H-Ras and N-Ras play relatively minor roles in mouse morphogenesis and development, even though it has been well established that these proteins do play crucial roles in signal transduction in cell proliferation and differentiation. In adult mice, the relative levels of expression of the three ras genes vary among different types of tissue (Leon et al., 1987) . For example, in the adult brain, where cell proliferation does not normally occur, the H-ras gene was dominantly expressed, and our analysis of H-ras-deficient mice revealed an important role for H-ras in synaptic transmission (Manabe et al., 2000) .
While K-Ras appears to have a distinct function in embryonic development of the heart, the presence of a more severe phenotype, such as earlier embryonic death, in double ras mutant mice than that in single K-ras mutants suggests that a certain relationship exists between K-Ras and either N-Ras or H-Ras in mouse development. We found that the N-ras
genotype was lethal either embryonically or neonatally, while N-ras À/À /K-ras
and N-ras
mice were fully viable. In addition, most H-ras
embryos died between E9.5 and E11.5, while the embryos lacking only H-ras or K-ras genes were viable at the same stage. The exacerbation of the K-ras phenotype in the double mutant mice thus suggests functional cooperation of the different Ras proteins in certain systems such as the hematopoietic, cardiovascular or nervous system, since abnormal hematopoietic development and neuronal cell death (Johnson et al., 1997) and vascular system defects and neuronal apoptosis (Koera et al., 1997) have been observed in K-ras À/À mice as well as in mice lacking Ras GAP, a negative regulator of Ras (Henkemeyer et al., 1995) .
Since no triple ras deficient mouse embryos were obtained, Ras function appears to be indispensable for the early development of mouse embryos. In our ongoing studies, we have developed human H-ras transgenic mice that, unlike the H-ras transgenic mice of the present study, carried a single copy of excisable loxP-flanked human H-ras transgene. We found that the transgene rescued K-ras null mutant mice from embryonic lethality. Prompted by this finding, we are currently generating triple ras mutant mice carrying an excisable H-ras transgene that can be conditionally inactivated by Cre-mediated recombination. This new series of studies will help us address a number of questions, including whether ras genes are essential or dispensable for certain types of cell or tissue during embryonic development or in adulthood. Partial functional overlap of three ras genes in mouse K Nakamura et al
Materials and methods
Generation of Ras mutant mice
H-ras genomic clones were isolated from a 129/Sv mouse genomic library (Stratagene, La Jolla, CA, USA) using v-Haras as a probe. The targeting vector was constructed using the following DNA fragments: a 2.7 kb XbaI-XhoI fragment located 5 0 of exon f, a 5.8 kb SpeI-XbaI fragment located in the 3 0 region of exon IV, a 1.1 kb fragment containing a neo gene derived from pMC1neo-polyA (Stratagene), a 1.0 kb fragment containing the DT-A gene for negative selection (Yagi et al., 1990) and the plasmid pBluescript (Stratagene). N-ras genomic clones were isolated from a 129/Sv mouse genomic library (Stratagene) using N-ras cDNA as a probe. The targeting vector was constructed using the following DNA fragments: a 1.8 kb XbaI-PstI fragment located 5 0 of exon f, a 4.9 kb XbaI-SpeI fragment containing exons III, IV, V and the 5 0 part of exon VI, a 1.1 kb fragment containing a neo gene derived from pMC1neo-polyA, a 1.0 kb fragment containing DT-A and the plasmid pBluescript. Construction of the targeting vector for K-ras has been described previously (Koera et al., 1997) . CCE ES cells (Kuehn et al., 1987) (a gift from Dr E Robertson) obtained from an inbred mouse line (129/SvJ) were cultured essentially as described previously (Koera et al., 1997) . A 50 mg portion of the linearized targeting vector DNA was transfected into 4.7 Â 10 7 ES cells by electroporation at 270 V 1.8 mm À1 and 500 mF capacitance (ECM 600; BTX Inc., Holliston, MA, USA). Forty-eight hours after electroporation, G418 (250 mg ml À1 ; GibcoBRL) was added to the medium. DNA from G418-resistant ES clones was digested, and hybridized with a 5 0 -probe, 3 0 -probe and neo probe, as illustrated in Figure 2a . A targeted clone was injected into C57BL/6J blastocysts, and chimeric mice were thus generated. Chimeric males were mated with (C57BL/ 6 Â DBA/2) F1 or C57BL/6 females, and the tail DNA of the agouti offspring was analysed to confirm germline transmission of the targeted allele by Southern blotting.
Heterozygous mice were interbred to generate homozygous mice lacking the H-Ras protein, N-Ras protein or K-Ras protein. Double or triple ras mutant mice were generated by extensive breeding of single ras mutant mice by natural mating or in vitro fertilization. The multiple knockout mice were not backcrossed onto a pure genetic background.
PCR analysis
The nucleotide sequences of the PCR primers for determination of genotype were (5 0 -GCTCCCTATTTGTGTTGGTTT TGC-3 0 and 5 0 -CCGCAATTTATGCTGCCGAATCTC-3 0 ) for H-ras, (5 0 -CATATTTAAACAAAAGACGAATGC-3 0 and 5 0 -AACAGGATTCATTTCAGGCACAAC-3 0 ) for N-ras, (5 0 -GATAATCTTGTGTGAGACATGTTC-3 0 and 5 0 -CTGTA GAGCAGCGTTACCTCTATC-3 0 ) for K-ras and (5 0 -TCCTG CCGAGAAAGTATCCA-3 0 and 5 0 -ATCAGAGCAGCCGAT TGTCTGTTG-3 0 ) for neo.
Western blotting
Total protein was extracted from the kidney of H-ras mutant mice, from the lung of N-ras mutant mice or from the whole body of K-ras mutant embryos on E11.5. Total protein was separated by 10% SDS-PAGE and then blotted onto an Immobilon membrane (Millipore, Billerica, MA, USA), which was incubated with monoclonal anti-H-Ras antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA), monoclonal anti-N-Ras antibody (Santa Cruz Biotechnology) or monoclonal anti-K-Ras antibody (Santa Cruz Biotechnology). After washing the membrane, the antibody was visualized using an enhanced chemiluminescence detection system (Amersham, Little Chalfont, Bukinghamshire, UK).
In situ hybridization
The nucleotide sequences of the probes were complementary to nucleotide residues of the H-ras cDNA (5 0 -GCCAGGACC ACTCTCATCGGGTGGGTTCAGTTTCCGCAATTTATG-3 0 and 5 0 -GTGGAGGACTTGGGTGCCAGTGGCAACAGG GACAAGTTCATGACA-3 0 ), of the N-ras cDNA (5 0 -AC TTCAACCTGAGCTGTTGGAGACCCCGAAACCGCCA TGAACAGC-3 0 and 5 0 -TTCACACCAGCAAAAACCTCAA ACTCCGCAGCCCGCCTCGGGAGG-3 0 ) and of the K-ras cDNA (5 0 -GGAATCAACATGCATGCACCAAATCCCAA GACAGAGTCTGAGGTC-3 0 and 5 0 -GGAGCCTAAGTCT GTGACCCTCAGTGTCCAGTGAAAGCTGCGATT-3 0 ). In situ hybridization was carried out as described previously (Yamaguchi et al., 1996) and analysed using ImageJ 1.38v (available at http://rsb.info.nih.gov/ij).
Histological procedures
The embryos and tissues were removed, fixed in 4% paraformaldehyde, embedded in paraffin, sectioned at 5 mm and stained with hematoxylin and eosin for histological examination.
Statistical analysis w-square test was used to compare the observed and expected values.
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